Skip to content

Personalized Support for Progress (PSP) in a VA Women's Wellness Clinic

Pilot Trial of Personalized Support for Progress (PSP) in a VA Women's Wellness Clinic

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03908190
Enrollment
28
Registered
2019-04-09
Start date
2019-11-13
Completion date
2021-03-03
Last updated
2021-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emotional Stress, Life Stress, Psychological Stress

Keywords

Peer Support, Patient Navigators

Brief summary

The purpose of this study is to evaluate the Personalized Support for Progress (PSP) intervention in a Veterans Health Administration (VHA) Women's Wellness Clinic. PSP uses a peer support provider to help women identify their primary concern, develop a personalized plan to help address that concern, and provide practical and emotional support to implement the plan. The primary aim is to evaluate the feasibility, acceptability, and utility of PSP and the research protocol.

Interventions

BEHAVIORALPersonalized Support for Progress

Participants will receive the Personalized Support for Progress Intervention from a peer support provider including sessions with the peer support provider to complete a prioritization task, develop a personalized care plan, and receive support for implementing the personalized care plan.

Sponsors

US Department of Veterans Affairs
CollaboratorFED
Syracuse VA Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Masking description

The interviewer evaluating progress towards goals will be blinded to condition.

Intervention model description

Randomized Controlled Trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Veteran status (non-Veterans will not be enrolled in this trial) * Enrollment in the Syracuse VA Medical Center Women's Wellness Clinic * Report high stress within the last month (Perceived Stress Scale \[PSS-10\] \> 18) * Primary Care Provider approval for participation * Ability to communicate in English including reading, writing, hearing, and speaking well enough to complete research and intervention tasks.

Exclusion criteria

* Any Veteran with higher suicide risk on the P4 or Veterans with lower suicide risk on the P4 and evaluated by the PI or another clinician to be clinically unstable or at risk * Homicidality (screened via adaptation of the P4 screener and evaluated on the same criteria above) * Homelessness (including literally homeless, imminent risk of homelessness, or fleeing/attempting to flee domestic violence per VA definitions) * Veterans who are enrolled in or have had psychotherapy or changes to psychotropic medications in the last 12 weeks * Veterans with impairment that would not allow them to engage in PSP including active psychosis, cognitive deficits, severe substance use requiring detoxification (documented in CPRS or reported by a PACT member) * Veterans who are not available for outpatient PSP meetings (e.g., in a residential program) * Veterans who have current VA or non-VA peer support engagement (an appointment within the last month and/or additional follow-up scheduled)

Design outcomes

Primary

MeasureTime frameDescription
Assessment Retention Rate6 monthsThis is an assessment of trial feasibility.
Intervention Retention Rate6 monthsThis is an assessment of trial feasibility.
Client Satisfaction Questionnaire6 monthsThis scale measures satisfaction and ranges from 8-24 with higher scores indicating higher satisfaction.
Goal Attainment Scaling6 monthsThis interview assesses progress toward individualized goals on a -2 to 2 scale with higher scores indicating more progress toward goals.
Perceived Stress Scale (PSS-10)6 monthsThis scale evaluates perceived stress and ranges from 0-40 with lower scores indicating lower levels of perceived stress.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026